Mineral-Homeostasis in Continuous Renal Replacement Therapy

Completed

• Conditions: Acute Renal Failure

• Registration Number: NCT01946113
• Lead Sponsor: Heinrich-Heine University, Duesseldorf

Brief Summary

Acute renal failure is a common complication in intensive care unit patients. In 10% of cases renal replacement therapy becomes necessary. Current devices have increase filter patency and efficacy. However, magnesium, calcium and phosphate are eliminated as well. However, the extend of this elimination hase not been quantified. Thus, we want to

1. record retrospectively how often abnormal values for phosphate, magnesium and calcium occurred during routine renal replacement therapy in 2011 and 2012.

2. prospectively evaluate the same parameters during routine treatment in 2013 and 2014

Detailed Description

Not available

Study Timeline

• Study Start: 2013-09
• Study First Submitted: 2013-09-09
• Study First Submitted QC: 2013-09-16
• Study First Posted: 2013-09-19
• Status Verified: 2015-08
• Primary Completion: 2015-08
• Study Completion: 2015-08
• Last Update Submitted: 2015-08-19
• Last Update Posted: 2015-08-20

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

• intensive care unit patients with acute renal failure undergoing continuous renal replacement therapy
• older than 18 years of age

Exclusion Criteria

• age less than 18 years
• pregnancy
• contraindications against continuous renal replacement therapy

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Incidence of hypo-phosphate,-magnesium and calcaemia	approximately 28 days	Participants will be followed for the duration of ICU stay, an expected average of 28 days

Trial Locations

Locations (1)

Interdisziplinäre Intensivstation Universitätsklinikum Düsseldorf; 🇩🇪 Düsseldorf, Germany